- Home
- BANL vs TPST Comparison
BANL vs TPST Comparison
Compare BANL & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- TPST
- Stock Information
- Founded
- BANL 2015
- TPST 2011
- Country
- BANL Malaysia
- TPST United States
- Employees
- BANL N/A
- TPST N/A
- Industry
- BANL Oil Refining/Marketing
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- BANL Energy
- TPST Health Care
- Exchange
- BANL Nasdaq
- TPST Nasdaq
- Market Cap
- BANL 25.3M
- TPST 33.0M
- IPO Year
- BANL 2023
- TPST N/A
- Fundamental
- Price
- BANL $0.80
- TPST $6.92
- Analyst Decision
- BANL
- TPST Hold
- Analyst Count
- BANL 0
- TPST 3
- Target Price
- BANL N/A
- TPST $30.00
- AVG Volume (30 Days)
- BANL 549.4K
- TPST 86.6K
- Earning Date
- BANL 04-16-2025
- TPST 08-07-2025
- Dividend Yield
- BANL N/A
- TPST N/A
- EPS Growth
- BANL N/A
- TPST N/A
- EPS
- BANL N/A
- TPST N/A
- Revenue
- BANL $592,517,545.00
- TPST N/A
- Revenue This Year
- BANL N/A
- TPST N/A
- Revenue Next Year
- BANL N/A
- TPST N/A
- P/E Ratio
- BANL N/A
- TPST N/A
- Revenue Growth
- BANL 35.93
- TPST N/A
- 52 Week Low
- BANL $0.55
- TPST $5.35
- 52 Week High
- BANL $1.35
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- BANL 46.54
- TPST 46.64
- Support Level
- BANL $0.71
- TPST $7.06
- Resistance Level
- BANL $1.03
- TPST $7.64
- Average True Range (ATR)
- BANL 0.08
- TPST 0.26
- MACD
- BANL -0.01
- TPST 0.00
- Stochastic Oscillator
- BANL 25.87
- TPST 22.10
About BANL CBL International Limited
CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.